The prevalence of oral leukoplakia in 138 patients with oral squamous cell carcinoma
- PMID: 15533209
- DOI: 10.1111/j.1601-0825.2004.01031.x
The prevalence of oral leukoplakia in 138 patients with oral squamous cell carcinoma
Abstract
Objectives: To determine the relationship between oral leukoplakia (OL) and oral squamous cell carcinoma (OSCC), and to evaluate possible differences between those carcinomas with and without associated leukoplakia.
Material and methods: A total of 138 patients were studied at the Stomatology Service of the University General Hospital, Valencia, Spain. These patients were divided into two groups: group 1, patients with oral cancer and leukoplakia, and group 2, patients with OSCC but with no associated premalignant lesions. The relationship between this precancerous lesion and the OSCC was evaluated, as well as the possible clinical and histological differences between the tumours of the two groups.
Results: Leukoplakia was detected in 27 (19.56%) patients with OSCC. No differences were found between the two groups regarding age and tumour location. However, statistically significant differences were observed with respect to the form, tumour stage and the presence of adenopathies in the cancers with and without leukoplakia; in that the tumours associated with leukoplakia were diagnosed as being at a more initial stage.
Conclusions: Those patients with OL associated with oral cancer presented with tumours at a less advanced stage than those where no associated leukoplakia existed.
Similar articles
-
Epstein-Barr virus prevalence in oral squamous cell cancer and in potentially malignant oral disorders in an eastern Hungarian population.Eur J Oral Sci. 2009 Oct;117(5):536-40. doi: 10.1111/j.1600-0722.2009.00660.x. Eur J Oral Sci. 2009. PMID: 19758249
-
Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.Head Neck. 2009 Aug;31(8):1039-48. doi: 10.1002/hed.21071. Head Neck. 2009. PMID: 19340865
-
Genotypic determination by PCR-RFLP of human papillomavirus in normal oral mucosa, oral leukoplakia and oral squamous cell carcinoma samples in Madrid (Spain).Anticancer Res. 2008 Nov-Dec;28(6A):3733-41. Anticancer Res. 2008. PMID: 19189658
-
Molecular genetics of premalignant oral lesions.Oral Dis. 2007 Mar;13(2):126-33. doi: 10.1111/j.1601-0825.2006.01349.x. Oral Dis. 2007. PMID: 17305612 Review.
-
The results of CO2 laser surgery in patients with oral leukoplakia: a 25 year follow up.Oral Oncol. 2005 Jan;41(1):31-7. doi: 10.1016/j.oraloncology.2004.06.010. Oral Oncol. 2005. PMID: 15598583 Review.
Cited by
-
A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer.Nat Commun. 2022 Aug 17;13(1):4829. doi: 10.1038/s41467-022-31859-3. Nat Commun. 2022. PMID: 35977936 Free PMC article.
-
Neuropathic and nociceptive pain in head and neck cancer patients receiving radiation therapy.Head Neck Oncol. 2009 Jul 14;1:26. doi: 10.1186/1758-3284-1-26. Head Neck Oncol. 2009. PMID: 19594943 Free PMC article.
-
Notch1 mutations are drivers of oral tumorigenesis.Cancer Prev Res (Phila). 2015 Apr;8(4):277-286. doi: 10.1158/1940-6207.CAPR-14-0257. Epub 2014 Nov 18. Cancer Prev Res (Phila). 2015. PMID: 25406187 Free PMC article.
-
Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients.BMC Cancer. 2010 Dec 16;10:685. doi: 10.1186/1471-2407-10-685. BMC Cancer. 2010. PMID: 21159209 Free PMC article.
-
In silico analysis of pathways activation landscape in oral squamous cell carcinoma and oral leukoplakia.Cell Death Discov. 2017 May 22;3:17022. doi: 10.1038/cddiscovery.2017.22. eCollection 2017. Cell Death Discov. 2017. PMID: 28580171 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical